Cargando…
Recombinant Human Erythropoietin Augments Neovascularization Responses in a Neonatal Rat Model of Premature Brain Damage by Phosphatidylinositol 3 Kinase/Akt Pathway
BACKGROUND: Recombinant human-erythropoietin (rh-EPO) has therapeutic efficacy for premature infants with brain damage during the active rehabilitation and anti-inflammation. In the present study, we found that the rh-EPO was related to the promotion of neovascularization. Our aim was to investigate...
Autores principales: | Yu, Da-Fan, Zhu, Li-Hua, Jiang, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5381320/ https://www.ncbi.nlm.nih.gov/pubmed/28345550 http://dx.doi.org/10.4103/0366-6999.202744 |
Ejemplares similares
-
Comparison of Oral Recombinant Erythropoietin and Subcutaneous Recombinant Erythropoietin in Prevention of Anemia of Prematurity
por: Saeidi, R, et al.
Publicado: (2012) -
The Recombinant Human Erythropoietin Administered in Neonatal Rats After Excitotoxic Damage Induces Molecular Changes in the Hippocampus
por: Rivera-Cervantes, Martha Catalina, et al.
Publicado: (2019) -
Tubular immaturity causes erythropoietin-deficiency anemia of prematurity in preterm neonates
por: Asada, Nariaki
Publicado: (2018) -
Extended Combined Neonatal Treatment With Erythropoietin Plus Melatonin Prevents Posthemorrhagic Hydrocephalus of Prematurity in Rats
por: Robinson, Shenandoah, et al.
Publicado: (2018) -
Activated Phosphatidylinositol 3-Kinase and Akt Kinase Promote Survival of Superior Cervical Neurons
por: Philpott, Karen L., et al.
Publicado: (1997)